Fridays vs Hers: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Fridays beats Hers overall, scoring 8.7/10 vs 7.3/10. Hers is more affordable at $199/mo vs $249/mo. Choose Fridays for users who want a holistic program with coaching, nutrition s. Choose Hers for women who want brand-name wegovy (injection or pill) at $149.

A side-by-side comparison of Fridays and Hers covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Fridays

#3 of 48

8.7/10

Holistic weight loss program combining GLP-1 medications with lifestyle coaching, nutrition guidance, and ongoing support.

Visit Fridays

Hers

#35 of 48

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers

Feature	Fridays	Hers
Our Score	8.7/10	7.3/10
Starting Price	$249/mo	$199/mo
Medication Type	Both	Both
Insurance Accepted	Yes	No
Best For	Users who want a holistic program with coaching, nutrition support, and flexible pricing	Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand
Ranking	#3	#35

Pros & Cons Compared

Fridays

Pros

+One of the few platforms that bills insurance directly — can reduce out-of-pocket to $25-50/mo with coverage
+Includes 1-on-1 nutrition coaching and weekly check-ins, not just medication prescriptions
+Offers brand-name Wegovy/Zepbound and compounded options — switches based on insurance formulary
+Flexible plans: medication-only ($249/mo) or full coaching program ($299/mo)

Cons

−The coaching-heavy model adds complexity — three different plan tiers with different inclusions
−Without insurance, $249/mo for medication-only is above average for what you get clinically

Hers

Pros

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

Our Verdict

Fridays edges out Hers with a score of 8.7/10 vs 7.3/10. If budget is your priority, Hers starts at $199/mo compared to Fridays's $249/mo. Fridays accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Fridays if you want: users who want a holistic program with coaching, nutrition support, and flexible pricing. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Fridays nor Hers feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review